Daewoo Engineering & Construction Co. will develop wearable robots that can be worn by construction workers that could help prevent musculoskeletal disorders and maintain productivity.
The wearable robots consist of a waist support robot and a walking assistance robot. It will have sensors that will gather and analyze information about the workers' posture, weight, and working practices.
If their safety and efficacy are proven, Daewoo E&C will increase the supply of these robots to other industrial areas.
The company was selected in a contest held by the Korea Institute for Robot Industry Advancement to work in cooperation with local robotics startup Wirobotics and the Korea Orthopedics and Rehabilitation Center to develop and demonstrate smart work care services using wearable robot solutions.
The three parties, including Daewoo E&C, proposed the wearable robot and smart work care services concerning construction workers’ musculoskeletal issues and sustainable productivity.


Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



